D
WPD Pharmaceuticals Inc.
WPDPF
$0.00
-$0.025-100.00%
D
Sell
12/24/2024Upgraded
WPD Pharmaceuticals Inc. (WPDPF) was upgraded to D from D- on 12/24/2024 due to a significant increase in the efficiency index, total return index and volatility index. Net income increased 350.36% from -$13.9 to $34.8, and total capital increased 30% from -$244.7 to -$171.3.
WPD Pharmaceuticals Inc. (WPDPF) was upgraded to D from D- on 12/24/2024 due to a significant increase in the efficiency index, total return index and volatility index. Net income increased 350.36% from -$13.9 to $34.8, and total capital increased 30% from -$244.7 to -$171.3.
D
Sell
6/7/2024Upgraded
WPD Pharmaceuticals Inc. (WPDPF) was upgraded to D- from E+ on 6/7/2024 due to a noticeable increase in the growth index, efficiency index and volatility index.
WPD Pharmaceuticals Inc. (WPDPF) was upgraded to D- from E+ on 6/7/2024 due to a noticeable increase in the growth index, efficiency index and volatility index.
E
Sell
2/6/2024Downgrade
WPD Pharmaceuticals Inc. (WPDPF) was downgraded to E+ from D- on 2/6/2024 due to a substantial decline in the growth index and solvency index. Operating cash flow declined 292.21% from -$15.4 to -$60.4, earnings per share declined from -$0.0002 to -$0.0005, and EBIT declined 135.5% from -$23.1 to -$54.4.
WPD Pharmaceuticals Inc. (WPDPF) was downgraded to E+ from D- on 2/6/2024 due to a substantial decline in the growth index and solvency index. Operating cash flow declined 292.21% from -$15.4 to -$60.4, earnings per share declined from -$0.0002 to -$0.0005, and EBIT declined 135.5% from -$23.1 to -$54.4.
D
Sell
12/7/2022Downgrade
WPD Pharmaceuticals Inc. (WPDPF) was downgraded to D- from D on 12/7/2022 due to a decline in the volatility index.
WPD Pharmaceuticals Inc. (WPDPF) was downgraded to D- from D on 12/7/2022 due to a decline in the volatility index.
D
Sell
7/28/2022Upgraded
WPD Pharmaceuticals Inc. (WPDPF) was upgraded to D from D- on 7/28/2022 due to a substantial increase in the valuation index and volatility index.
WPD Pharmaceuticals Inc. (WPDPF) was upgraded to D from D- on 7/28/2022 due to a substantial increase in the valuation index and volatility index.
D
Sell
7/13/2022Downgrade
WPD Pharmaceuticals Inc. (WPDPF) was downgraded to D- from D on 7/13/2022 due to a decline in the volatility index.
WPD Pharmaceuticals Inc. (WPDPF) was downgraded to D- from D on 7/13/2022 due to a decline in the volatility index.
D
Sell
6/23/2022Upgraded
WPD Pharmaceuticals Inc. (WPDPF) was upgraded to D from D- on 6/23/2022 due to an increase in the volatility index.
WPD Pharmaceuticals Inc. (WPDPF) was upgraded to D from D- on 6/23/2022 due to an increase in the volatility index.
D
Sell
6/6/2022Downgrade
WPD Pharmaceuticals Inc. (WPDPF) was downgraded to D- from D on 6/6/2022 due to a decline in the volatility index.
WPD Pharmaceuticals Inc. (WPDPF) was downgraded to D- from D on 6/6/2022 due to a decline in the volatility index.
D
Sell
5/17/2022Upgraded
WPD Pharmaceuticals Inc. (WPDPF) was upgraded to D from E+ on 05/17/2022.
WPD Pharmaceuticals Inc. (WPDPF) was upgraded to D from E+ on 05/17/2022.
E
Sell
5/13/2022Downgrade
WPD Pharmaceuticals Inc. (WPDPF) was downgraded to E+ from D on 05/13/2022.
WPD Pharmaceuticals Inc. (WPDPF) was downgraded to E+ from D on 05/13/2022.
D
Sell
5/4/2022Upgraded
WPD Pharmaceuticals Inc. (WPDPF) was upgraded to D from E+ on 05/04/2022.
WPD Pharmaceuticals Inc. (WPDPF) was upgraded to D from E+ on 05/04/2022.
E
Sell
5/1/2022Downgrade
WPD Pharmaceuticals Inc. (WPDPF) was downgraded to E+ from D on 5/1/2022 due to a decline in the volatility index.
WPD Pharmaceuticals Inc. (WPDPF) was downgraded to E+ from D on 5/1/2022 due to a decline in the volatility index.
D
Sell
4/21/2022Upgraded
WPD Pharmaceuticals Inc. (WPDPF) was upgraded to D from E+ on 4/21/2022 due to an increase in the volatility index.
WPD Pharmaceuticals Inc. (WPDPF) was upgraded to D from E+ on 4/21/2022 due to an increase in the volatility index.
E
Sell
4/20/2022Downgrade
WPD Pharmaceuticals Inc. (WPDPF) was downgraded to E+ from D- on 04/20/2022.
WPD Pharmaceuticals Inc. (WPDPF) was downgraded to E+ from D- on 04/20/2022.
D
Sell
4/18/2022Downgrade
WPD Pharmaceuticals Inc. (WPDPF) was downgraded to D- from D on 4/18/2022 due to a decline in the volatility index.
WPD Pharmaceuticals Inc. (WPDPF) was downgraded to D- from D on 4/18/2022 due to a decline in the volatility index.
D
Sell
2/11/2022Upgraded
WPD Pharmaceuticals Inc. (WPDPF) was upgraded to D from D- on 2/11/2022 due to an increase in the volatility index.
WPD Pharmaceuticals Inc. (WPDPF) was upgraded to D from D- on 2/11/2022 due to an increase in the volatility index.
D
Sell
1/26/2022Downgrade
WPD Pharmaceuticals Inc. (WPDPF) was downgraded to D- from D on 1/26/2022 due to a decline in the volatility index and valuation index.
WPD Pharmaceuticals Inc. (WPDPF) was downgraded to D- from D on 1/26/2022 due to a decline in the volatility index and valuation index.
D
Sell
1/7/2022Upgraded
WPD Pharmaceuticals Inc. (WPDPF) was upgraded to D from D- on 1/7/2022 due to an increase in the volatility index.
WPD Pharmaceuticals Inc. (WPDPF) was upgraded to D from D- on 1/7/2022 due to an increase in the volatility index.
D
Sell
12/23/2021Downgrade
WPD Pharmaceuticals Inc. (WPDPF) was downgraded to D- from D on 12/23/2021 due to a decline in the volatility index and total return index.
WPD Pharmaceuticals Inc. (WPDPF) was downgraded to D- from D on 12/23/2021 due to a decline in the volatility index and total return index.
D
Sell
12/1/2021Upgraded
WPD Pharmaceuticals Inc. (WPDPF) was upgraded to D from D- on 12/1/2021 due to an increase in the growth index. Earnings per share increased from -$0.0088 to -$0.005, and EBIT increased 20.8% from -$1.1M to -$870.3.
WPD Pharmaceuticals Inc. (WPDPF) was upgraded to D from D- on 12/1/2021 due to an increase in the growth index. Earnings per share increased from -$0.0088 to -$0.005, and EBIT increased 20.8% from -$1.1M to -$870.3.
D
Sell
11/23/2021Upgraded
WPD Pharmaceuticals Inc. (WPDPF) was upgraded to D- from E+ on 11/23/2021 due to an increase in the volatility index and valuation index.
WPD Pharmaceuticals Inc. (WPDPF) was upgraded to D- from E+ on 11/23/2021 due to an increase in the volatility index and valuation index.
E
Sell
11/8/2021Downgrade
WPD Pharmaceuticals Inc. (WPDPF) was downgraded to E+ from D- on 11/08/2021.
WPD Pharmaceuticals Inc. (WPDPF) was downgraded to E+ from D- on 11/08/2021.
D
Sell
11/5/2021Downgrade
WPD Pharmaceuticals Inc. (WPDPF) was downgraded to D- from D on 11/5/2021 due to a decline in the volatility index and valuation index.
WPD Pharmaceuticals Inc. (WPDPF) was downgraded to D- from D on 11/5/2021 due to a decline in the volatility index and valuation index.
D
Sell
10/21/2021Upgraded
WPD Pharmaceuticals Inc. (WPDPF) was upgraded to D from D- on 10/21/2021 due to an increase in the volatility index.
WPD Pharmaceuticals Inc. (WPDPF) was upgraded to D from D- on 10/21/2021 due to an increase in the volatility index.
D
Sell
9/17/2021Downgrade
WPD Pharmaceuticals Inc. (WPDPF) was downgraded to D- from D on 9/17/2021 due to a decline in the volatility index and total return index.
WPD Pharmaceuticals Inc. (WPDPF) was downgraded to D- from D on 9/17/2021 due to a decline in the volatility index and total return index.
D
Sell
9/2/2021Upgraded
WPD Pharmaceuticals Inc. (WPDPF) was upgraded to D from D- on 9/2/2021 due to an increase in the valuation index and growth index. EBIT increased 35.39% from -$1.7M to -$1.1M, and operating cash flow increased 28.93% from -$125.8 to -$89.4.
WPD Pharmaceuticals Inc. (WPDPF) was upgraded to D from D- on 9/2/2021 due to an increase in the valuation index and growth index. EBIT increased 35.39% from -$1.7M to -$1.1M, and operating cash flow increased 28.93% from -$125.8 to -$89.4.
D
Sell
3/26/2021Upgraded
WPD Pharmaceuticals Inc. (WPDPF) was upgraded to D- from E+ on 3/26/2021 due to an increase in the volatility index and valuation index.
WPD Pharmaceuticals Inc. (WPDPF) was upgraded to D- from E+ on 3/26/2021 due to an increase in the volatility index and valuation index.
E
Sell
3/11/2021Downgrade
WPD Pharmaceuticals Inc. (WPDPF) was downgraded to E+ from D- on 3/11/2021 due to a decline in the volatility index.
WPD Pharmaceuticals Inc. (WPDPF) was downgraded to E+ from D- on 3/11/2021 due to a decline in the volatility index.
D
Sell
2/24/2021Upgraded
WPD Pharmaceuticals Inc. (WPDPF) was upgraded to D- from E+ on 2/24/2021 due to an increase in the growth index, volatility index and total return index. Operating cash flow increased 140.81% from $232.3 to $559.4, earnings per share increased from -$0.0144 to -$0.0084, and EBIT increased 32.85% from -$1.7M to -$1.14M.
WPD Pharmaceuticals Inc. (WPDPF) was upgraded to D- from E+ on 2/24/2021 due to an increase in the growth index, volatility index and total return index. Operating cash flow increased 140.81% from $232.3 to $559.4, earnings per share increased from -$0.0144 to -$0.0084, and EBIT increased 32.85% from -$1.7M to -$1.14M.
E
Sell
10/16/2020None
WPD Pharmaceuticals Inc. (WPDPF) was downgraded to E+ from U on 10/16/2020.
WPD Pharmaceuticals Inc. (WPDPF) was downgraded to E+ from U on 10/16/2020.
OTC PK
10/30/2024 2:02PM Eastern
Quotes delayed
